The Better Meat Co. Secures $31 Million in Series A to Scale Mycoprotein Production

The Better Meat Co. has secured $31 million in Series A financing to scale up its mycoprotein production. The funding will allow the company to commercialize its Rhiza mycoprotein ingredient, which offers improved yields, texture, lower saturated fat, and increased fiber in meat and plant-based products. BMC has achieved significant milestones, including reducing production costs by over 30% and securing regulatory approval for its Rhiza organism from the FDA, USDA, and Singapore authorities.

The company has signed Letters of Intent with major meat companies, received patents for its technology, and secured a supply deal with a South American meat company. With plans to expand its operations and increase production capacity, BMC aims to introduce a cost-effective and sustainable protein solution to the market. Steve Jurvetson of Future Ventures and Glenn Hickman of Hickman’s Family Farms will join BMC’s board of directors, recognizing the company's contribution to addressing the need for better protein sources.